Inventurus Knowledge Solutions Limited has informed the Exchange regarding a press release dated March 24, 2026, titled "IKS Health and Certilytics Expand Strategic Collaboration to Bridge the Payer-Provider Gap with Agentic AI and Human-in-the-Loop Oversight."
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
IKS Health has announced an expansion of its two-year strategic partnership with US-based healthcare analytics firm Certilytics to bridge the gap between healthcare payers and providers. The collaboration will integrate Certilytics' BrainstormAI® Studio and CertHLM™ tools with IKS Health's Agentic Care Enablement Platform, combining AI automation with human oversight. Three initial use cases have been identified: prior authorization (with a stated goal of handling 70%+ of workflows autonomously), proactive member engagement to close care gaps, and real-time consumer price transparency at the point of care. The announcement includes endorsements from both CEOs but no specific financial terms, deal value, revenue impact, or timelines are disclosed.
This is a strategic partnership expansion rather than a new revenue-generating contract, with no quantifiable financial details provided, so the near-term stock impact is likely limited. It reinforces IKS Health's positioning in the US healthcare AI/care enablement space, which is a positive long-term signal for the company's growth narrative, but shareholders will need to wait for concrete revenue disclosures to gauge actual business impact.